2020: The Year “The Dumb Money Was The Smart Money”
“The dumb money was the smart money this year,” is how one portfolio manager cited in today’s article sums up the wild swings experienced by…
2020 Investing
Why This Seemingly ‘Great Deal’ Pharma Stock Is Contraindicated
With a massive cash balance (and no debt), rapidly growing revenue and earnings, and a well-stocked pipeline, the pharma stock that’s the focus of today’s…
“Massive Upside Potential”: 10 Under $10 For 2020
“The big question for investors at the start of 2020 is what to do with new money that needs to be invested without paying the…